174 related articles for article (PubMed ID: 22849651)
1. CRISPR transcript processing: a mechanism for generating a large number of small interfering RNAs.
Djordjevic M; Djordjevic M; Severinov K
Biol Direct; 2012 Jul; 7():24. PubMed ID: 22849651
[TBL] [Abstract][Full Text] [Related]
2. Function and regulation of clustered regularly interspaced short palindromic repeats (CRISPR) / CRISPR associated (Cas) systems.
Richter C; Chang JT; Fineran PC
Viruses; 2012 Oct; 4(10):2291-311. PubMed ID: 23202464
[TBL] [Abstract][Full Text] [Related]
3. Substrate generation for endonucleases of CRISPR/cas systems.
Zoephel J; Dwarakanath S; Richter H; Plagens A; Randau L
J Vis Exp; 2012 Sep; (67):. PubMed ID: 22986408
[TBL] [Abstract][Full Text] [Related]
4. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.
Fonfara I; Richter H; Bratovič M; Le Rhun A; Charpentier E
Nature; 2016 Apr; 532(7600):517-21. PubMed ID: 27096362
[TBL] [Abstract][Full Text] [Related]
5. Mature clustered, regularly interspaced, short palindromic repeats RNA (crRNA) length is measured by a ruler mechanism anchored at the precursor processing site.
Hatoum-Aslan A; Maniv I; Marraffini LA
Proc Natl Acad Sci U S A; 2011 Dec; 108(52):21218-22. PubMed ID: 22160698
[TBL] [Abstract][Full Text] [Related]
6. A complex of Cas proteins 5, 6, and 7 is required for the biogenesis and stability of clustered regularly interspaced short palindromic repeats (crispr)-derived rnas (crrnas) in Haloferax volcanii.
Brendel J; Stoll B; Lange SJ; Sharma K; Lenz C; Stachler AE; Maier LK; Richter H; Nickel L; Schmitz RA; Randau L; Allers T; Urlaub H; Backofen R; Marchfelder A
J Biol Chem; 2014 Mar; 289(10):7164-7177. PubMed ID: 24459147
[TBL] [Abstract][Full Text] [Related]
7. A ruler protein in a complex for antiviral defense determines the length of small interfering CRISPR RNAs.
Hatoum-Aslan A; Samai P; Maniv I; Jiang W; Marraffini LA
J Biol Chem; 2013 Sep; 288(39):27888-97. PubMed ID: 23935102
[TBL] [Abstract][Full Text] [Related]
8. Approaches to study CRISPR RNA biogenesis and the key players involved.
Behler J; Hess WR
Methods; 2020 Feb; 172():12-26. PubMed ID: 31325492
[TBL] [Abstract][Full Text] [Related]
9. Determining the Specificity of Cascade Binding, Interference, and Primed Adaptation
Cooper LA; Stringer AM; Wade JT
mBio; 2018 Apr; 9(2):. PubMed ID: 29666291
[TBL] [Abstract][Full Text] [Related]
10. Cross-cleavage activity of Cas6b in crRNA processing of two different CRISPR-Cas systems in Methanosarcina mazei Gö1.
Nickel L; Ulbricht A; Alkhnbashi OS; Förstner KU; Cassidy L; Weidenbach K; Backofen R; Schmitz RA
RNA Biol; 2019 Apr; 16(4):492-503. PubMed ID: 30153081
[TBL] [Abstract][Full Text] [Related]
11. Essential requirements for the detection and degradation of invaders by the Haloferax volcanii CRISPR/Cas system I-B.
Maier LK; Lange SJ; Stoll B; Haas KA; Fischer S; Fischer E; Duchardt-Ferner E; Wöhnert J; Backofen R; Marchfelder A
RNA Biol; 2013 May; 10(5):865-74. PubMed ID: 23594992
[TBL] [Abstract][Full Text] [Related]
12. RcsB-BglJ-mediated activation of Cascade operon does not induce the maturation of CRISPR RNAs in E. coli K12.
Arslan Z; Stratmann T; Wurm R; Wagner R; Schnetz K; Pul Ü
RNA Biol; 2013 May; 10(5):708-15. PubMed ID: 23392250
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of E. coli CRISPR-cas promoters and their silencing by H-NS.
Pul U; Wurm R; Arslan Z; Geissen R; Hofmann N; Wagner R
Mol Microbiol; 2010 Mar; 75(6):1495-512. PubMed ID: 20132443
[TBL] [Abstract][Full Text] [Related]
14. Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity.
Charpentier E; Richter H; van der Oost J; White MF
FEMS Microbiol Rev; 2015 May; 39(3):428-41. PubMed ID: 25994611
[TBL] [Abstract][Full Text] [Related]
15. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems.
Chylinski K; Le Rhun A; Charpentier E
RNA Biol; 2013 May; 10(5):726-37. PubMed ID: 23563642
[TBL] [Abstract][Full Text] [Related]
16. Processing-independent CRISPR RNAs limit natural transformation in Neisseria meningitidis.
Zhang Y; Heidrich N; Ampattu BJ; Gunderson CW; Seifert HS; Schoen C; Vogel J; Sontheimer EJ
Mol Cell; 2013 May; 50(4):488-503. PubMed ID: 23706818
[TBL] [Abstract][Full Text] [Related]
17. Characterization of CRISPR RNA processing in Clostridium thermocellum and Methanococcus maripaludis.
Richter H; Zoephel J; Schermuly J; Maticzka D; Backofen R; Randau L
Nucleic Acids Res; 2012 Oct; 40(19):9887-96. PubMed ID: 22879377
[TBL] [Abstract][Full Text] [Related]
18. RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes.
East-Seletsky A; O'Connell MR; Burstein D; Knott GJ; Doudna JA
Mol Cell; 2017 May; 66(3):373-383.e3. PubMed ID: 28475872
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium tuberculosis type III-A CRISPR/Cas system crRNA and its maturation have atypical features.
Wei W; Zhang S; Fleming J; Chen Y; Li Z; Fan S; Liu Y; Wang W; Wang T; Liu Y; Ren B; Wang M; Jiao J; Chen Y; Zhou Y; Zhou Y; Gu S; Zhang X; Wan L; Chen T; Zhou L; Chen Y; Zhang XE; Li C; Zhang H; Bi L
FASEB J; 2019 Jan; 33(1):1496-1509. PubMed ID: 29979631
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas systems and RNA-guided interference.
Barrangou R
Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
